347 related articles for article (PubMed ID: 37415185)
1. Etiology of super-enhancer reprogramming and activation in cancer.
Zhou RW; Parsons RE
Epigenetics Chromatin; 2023 Jul; 16(1):29. PubMed ID: 37415185
[TBL] [Abstract][Full Text] [Related]
2. Super-enhancers in cancer.
Thandapani P
Pharmacol Ther; 2019 Jul; 199():129-138. PubMed ID: 30885876
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic super-enhancers in cancer: mechanisms and therapeutic targets.
Bacabac M; Xu W
Cancer Metastasis Rev; 2023 Jun; 42(2):471-480. PubMed ID: 37059907
[TBL] [Abstract][Full Text] [Related]
4. Metabolic reprogramming directed by super-enhancers in tumors: An emerging landscape.
Zhou Z; Li J; Ousmane D; Peng L; Yuan X; Wang J
Mol Ther; 2024 Mar; 32(3):572-579. PubMed ID: 38327048
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional dysregulation by aberrant enhancer activation and rewiring in cancer.
Okabe A; Kaneda A
Cancer Sci; 2021 Jun; 112(6):2081-2088. PubMed ID: 33728716
[TBL] [Abstract][Full Text] [Related]
6. The molecular understanding of super-enhancer dysregulation in cancer.
Yoshino S; Suzuki HI
Nagoya J Med Sci; 2022 May; 84(2):216-229. PubMed ID: 35967935
[TBL] [Abstract][Full Text] [Related]
7. A local tumor microenvironment acquired super-enhancer induces an oncogenic driver in colorectal carcinoma.
Zhou RW; Xu J; Martin TC; Zachem AL; He J; Ozturk S; Demircioglu D; Bansal A; Trotta AP; Giotti B; Gryder B; Shen Y; Wu X; Carcamo S; Bosch K; Hopkins B; Tsankov A; Steinhagen R; Jones DR; Asara J; Chipuk JE; Brody R; Itzkowitz S; Chio IIC; Hasson D; Bernstein E; Parsons RE
Nat Commun; 2022 Oct; 13(1):6041. PubMed ID: 36253360
[TBL] [Abstract][Full Text] [Related]
8. Super-enhancers in the control of cell identity and disease.
Hnisz D; Abraham BJ; Lee TI; Lau A; Saint-André V; Sigova AA; Hoke HA; Young RA
Cell; 2013 Nov; 155(4):934-47. PubMed ID: 24119843
[TBL] [Abstract][Full Text] [Related]
9. Master transcription factors and mediator establish super-enhancers at key cell identity genes.
Whyte WA; Orlando DA; Hnisz D; Abraham BJ; Lin CY; Kagey MH; Rahl PB; Lee TI; Young RA
Cell; 2013 Apr; 153(2):307-19. PubMed ID: 23582322
[TBL] [Abstract][Full Text] [Related]
10. Super enhancers as master gene regulators in the pathogenesis of hematologic malignancies.
Dębek S; Juszczyński P
Biochim Biophys Acta Rev Cancer; 2022 Mar; 1877(2):188697. PubMed ID: 35150791
[TBL] [Abstract][Full Text] [Related]
11. Super-enhancers and novel therapeutic targets in colorectal cancer.
Liu Q; Guo L; Lou Z; Xiang X; Shao J
Cell Death Dis; 2022 Mar; 13(3):228. PubMed ID: 35277481
[TBL] [Abstract][Full Text] [Related]
12. Super-enhancers complexes zoom in transcription in cancer.
Wang M; Chen Q; Wang S; Xie H; Liu J; Huang R; Xiang Y; Jiang Y; Tian D; Bian E
J Exp Clin Cancer Res; 2023 Jul; 42(1):183. PubMed ID: 37501079
[TBL] [Abstract][Full Text] [Related]
13. Disruption of BRD4 at H3K27Ac-enriched enhancer region correlates with decreased c-Myc expression in Merkel cell carcinoma.
Sengupta D; Kannan A; Kern M; Moreno MA; Vural E; Stack B; Suen JY; Tackett AJ; Gao L
Epigenetics; 2015; 10(6):460-6. PubMed ID: 25941994
[TBL] [Abstract][Full Text] [Related]
14. Super-enhancers in transcriptional regulation and genome organization.
Wang X; Cairns MJ; Yan J
Nucleic Acids Res; 2019 Dec; 47(22):11481-11496. PubMed ID: 31724731
[TBL] [Abstract][Full Text] [Related]
15. [Research progress of super enhancer in cancer].
Wu ZQ; Mi ZY
Yi Chuan; 2019 Jan; 41(1):41-51. PubMed ID: 30686784
[TBL] [Abstract][Full Text] [Related]
16. Targeting super-enhancer activity for colorectal cancer therapy.
Voutsadakis IA
Am J Transl Res; 2024; 16(3):700-719. PubMed ID: 38586095
[TBL] [Abstract][Full Text] [Related]
17. Super-Enhancers Dysregulations in Hematological Malignancies.
Belloucif Y; Lobry C
Cells; 2022 Jan; 11(2):. PubMed ID: 35053311
[TBL] [Abstract][Full Text] [Related]
18. A multi-omic dissection of super-enhancer driven oncogenic gene expression programs in ovarian cancer.
Kelly MR; Wisniewska K; Regner MJ; Lewis MW; Perreault AA; Davis ES; Phanstiel DH; Parker JS; Franco HL
Nat Commun; 2022 Jul; 13(1):4247. PubMed ID: 35869079
[TBL] [Abstract][Full Text] [Related]
19. Selective inhibition of tumor oncogenes by disruption of super-enhancers.
Lovén J; Hoke HA; Lin CY; Lau A; Orlando DA; Vakoc CR; Bradner JE; Lee TI; Young RA
Cell; 2013 Apr; 153(2):320-34. PubMed ID: 23582323
[TBL] [Abstract][Full Text] [Related]
20. [ Super-enhancers. Are they regulators of regulatory genes of development and cancer?].
Didych DA; Tyulkina DV; Pleshkan VV; Alekseenko IV; Sverdlov ED
Mol Biol (Mosk); 2015; 49(6):915-22. PubMed ID: 26710770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]